organization · Reporting owner

UNITEDHEALTH GROUP INC

Disclosed activity across 2 companies

Tapewire entity: 2809
SEC CIK: 0000731766

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Evolent Health, Inc.EVH · Entity 5492	Director · Director by Deputization	June 01, 2018	June 05, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Evolent Health, Inc.

Report date June 01, 2018 · Filed June 05, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectSee footnote	0	Reported balance After 2018-06-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-06-01 · Sale · Disposed 2,861,065 · Balance 0 F1: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO.

Filing footnotes · ownership attribution and instrument terms

F1: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

DRUGMAX INC

Report date November 12, 2004 · Filed November 09, 2005

Jointly reported with United HealthCare Services, Inc.

Section 16 reporting ended · disclosed 2005-11-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	2,440,813	Reported balance Holding disclosure · report date 2004-11-12 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 2,440,813 F1: As previously reported on the Form 3 filed with the Securities and Exchange Commission on November 30, 2004, these shares are owned directly by United HealthCare Services, Inc. ("UHS"), which is a wholly owned subsidiary of UnitedHealth Group.
Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.61 · Expires 2011-04-30	IndirectSee Footnote	824,822	Reported balance Holding disclosure · report date 2004-11-12 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 824,822 F2: The initial calculation of warrants granted to UHS (815,917) as reported in the Form 3 filed on November 30, 2004 was a preliminary calculation of ownership by DrugMax, Inc. when DrugMax, Inc. acquired FamilyMeds, Inc., a privately-held company in November 2004 (UHS held securities of FamilyMeds which were converted into securities of DrugMax, Inc.). DrugMax, Inc. finalized its ownership calculations in June 2005, resulting in an additional 8,905 warrants issued (as of the date of the original issuance of warrants - November 12, 2004) to UHS. F1: As previously reported on the Form 3 filed with the Securities and Exchange Commission on November 30, 2004, these shares are owned directly by United HealthCare Services, Inc. ("UHS"), which is a wholly owned subsidiary of UnitedHealth Group.

Filing footnotes · ownership attribution and instrument terms

F1: As previously reported on the Form 3 filed with the Securities and Exchange Commission on November 30, 2004, these shares are owned directly by United HealthCare Services, Inc. ("UHS"), which is a wholly owned subsidiary of UnitedHealth Group.

F2: The initial calculation of warrants granted to UHS (815,917) as reported in the Form 3 filed on November 30, 2004 was a preliminary calculation of ownership by DrugMax, Inc. when DrugMax, Inc. acquired FamilyMeds, Inc., a privately-held company in November 2004 (UHS held securities of FamilyMeds which were converted into securities of DrugMax, Inc.). DrugMax, Inc. finalized its ownership calculations in June 2005, resulting in an additional 8,905 warrants issued (as of the date of the original issuance of warrants - November 12, 2004) to UHS.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 01, 2018 Filed Jun 5, 2018 00:03 UTC	Evolent Health, Inc. EVH · Entity 5492	SaleClass A Common Stock, par value $0.01 per share	2,861,065	$19.23	$55,018,279.95	Disclosure SEC source: 0000899243-18-015033 · doc4.xml · nonDerivative · entry 1 UNITEDHEALTH GROUP INC · CIK 0000731766 · Director · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.direct: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. F1 · ownership.nature: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. Read SEC document
March 05, 2018 Filed Mar 5, 2018 21:57 UTC	Evolent Health, Inc. EVH · Entity 5492	ConversionClass B Units and Class B Common Stock · Derivative	1,772,898	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-006359 · doc4.xml · derivative · entry 3 UNITEDHEALTH GROUP INC · CIK 0000731766 · Director · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,772,898 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc., Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of Evolent Health, Inc. on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among Evolent Health, Inc., ABCO and the other members party thereto. F2 · price: Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc., Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of Evolent Health, Inc. on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among Evolent Health, Inc., ABCO and the other members party thereto. F3 · price: On March 5, 2018, The Advisory Board Company exchanged 1,772,898 Class B Units (along with 1,772,898 Class B Shares) for 1,772,898 shares of Class A Common Stock. F2 · derivative.exercise_date: Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc., Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of Evolent Health, Inc. on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among Evolent Health, Inc., ABCO and the other members party thereto. F3 · derivative.exercise_date: On March 5, 2018, The Advisory Board Company exchanged 1,772,898 Class B Units (along with 1,772,898 Class B Shares) for 1,772,898 shares of Class A Common Stock. F2 · derivative.expiration_date: Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc., Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of Evolent Health, Inc. on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among Evolent Health, Inc., ABCO and the other members party thereto. F3 · derivative.expiration_date: On March 5, 2018, The Advisory Board Company exchanged 1,772,898 Class B Units (along with 1,772,898 Class B Shares) for 1,772,898 shares of Class A Common Stock. F1 · ownership.direct: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. F1 · ownership.nature: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. Read SEC document
March 05, 2018 Filed Mar 5, 2018 21:57 UTC	Evolent Health, Inc. EVH · Entity 5492	ConversionClass A Common Stock, par value $0.01 per share	1,772,898	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-006359 · doc4.xml · nonDerivative · entry 2 UNITEDHEALTH GROUP INC · CIK 0000731766 · Director · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,861,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc., Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of Evolent Health, Inc. on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among Evolent Health, Inc., ABCO and the other members party thereto. F3 · price: On March 5, 2018, The Advisory Board Company exchanged 1,772,898 Class B Units (along with 1,772,898 Class B Shares) for 1,772,898 shares of Class A Common Stock. F1 · ownership.direct: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. F1 · ownership.nature: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:57 UTC	Evolent Health, Inc. EVH · Entity 5492	SaleClass A Common Stock, par value $0.01 per share	3,040,000	$13.70	$41,648,000.00	Disclosure SEC source: 0000899243-18-006359 · doc4.xml · nonDerivative · entry 1 UNITEDHEALTH GROUP INC · CIK 0000731766 · Director · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,088,167 F1 · ownership.direct: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. F1 · ownership.nature: The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock of Evolent Health, Inc. (including the Class A Common Stock issued upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly-owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), which is an indirect, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"). UNH and OptumInsight may be deemed to beneficially own the securities beneficially owned by ABCO. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.